[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Deepika et al., 2022 - Google Patents

Preparation of Karkataka Taila, an Edible crab Rasayana, and assessment of its toxicological effects on SH-SY5Y cell line and on Drosophila melanogaster embryos

Deepika et al., 2022

View PDF
Document ID
1174580097809702348
Author
Deepika N
Baragur S
Naik M
Kalakotla S
Muhasina K
Ghosh P
Duraiswamy B
Publication year
Publication venue
Pharmacognosy Journal

External Links

Snippet

Background: Karkataka Taila (KT) is a virgin coconut oil (VCO) based Rasayana formulation that is enriched with the flesh of freshwater edible crab, Scylla serrata, used to treat Parkinson's Disease (PD) or Kampavata by local Ayurveda practitioners of Kerala state …
Continue reading at www.phcogj.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Braga et al. Azadirachta indica A. Juss. In vivo toxicity—an updated review
Pour et al. In vivo toxicity study of Lantana camara
Sidor et al. Drone brood homogenate as natural remedy for treating health care problem: a scientific and practical approach
Foudah et al. Rutin improves anxiety and reserpine-induced depression in rats
Abdelhalim et al. Potential effects of different natural antioxidants on inflammatory damage and oxidative-mediated hepatotoxicity induced by gold nanoparticles
Khan et al. In vitro and in vivo anthelmintic activities of Iris kashmiriana Linn.
Kim et al. Inhibitory effect of putranjivain A on allergic inflammation through suppression of mast cell activation
Buzdağlı et al. Effects of hesperidin on anti-inflammatory and antioxidant response in healthy people: a meta-analysis and meta-regression
Khumalo An inventory of the most popular medicinal barks sold on Johannesburg muthi markets and the antimicrobial activity of selected extracts and isolated chemical compounds
Li et al. Acute and developmental toxicity assessment of erincine A-enriched Hericium erinaceus mycelia in Sprague–Dawley rats
Bagameri et al. Molecular insights into royal jelly anti-inflammatory properties and related diseases
Mohamed et al. Sustained functioning impairments and oxidative stress with neurobehavioral dysfunction associated with oral nicotine exposure in the brain of a murine model of Ehrlich ascites carcinoma: modifying the antioxidant role of Chlorella vulgaris
Farag et al. The neonicotinoid thiacloprid interferes with the development, brain antioxidants, and neurochemistry of chicken embryos and alters the hatchling behavior: modulatory potential of phytochemicals
Pan et al. Ameliorative effects of silybin against avermectin-triggered carp spleen mitochondrial dysfunction and apoptosis through inhibition of PERK-ATF4-CHOP signaling pathway
García-Márquez et al. Antimicrobial and toxic activity of citronella essential oil (Cymbopogon nardus), and its effect on the growth and metabolism of gilthead seabream (sparus aurata l.)
Hamidian et al. Silymarin protects the structure of kidney in the neonatal rats exposed to maternal cadmium toxicity: A stereological study
Bok et al. Safety of 8-weeks oral administration of Arctium lappa L.
Deepika et al. Preparation of Karkataka Taila, an Edible crab Rasayana, and assessment of its toxicological effects on SH-SY5Y cell line and on Drosophila melanogaster embryos
Muñiz-Ramirez et al. Evaluation of the antidiabetic and antihyperlipidemic activity of spondias purpurea seeds in a diabetic zebrafish model
Serradell et al. Gill oxidative stress protection through the use of phytogenics and galactomannan oligosaccharides as functional additives in practical diets for European sea bass (Dicentrarchus labrax) juveniles
Perumal et al. Toxicity and teratogenicity evaluation of ethanolic extract from Momordica charantia fruit using zebrafish (Danio rerio) embryo model.
Ibrahim et al. Effect of Aqueous Stem Bark Extract of Parkia Biglobosa on the Histological Morphology of Liver of Adult Wistar Rats
Norazhar et al. Zebrafish Embryotoxicity and Teratogenic Effects of Christia vespertilionis Leaf Extract.
Aldulaimi et al. The effect of aqueous Urtica dioica extract in male rats exposed to copper sulfate poisoning
Docea et al. Effects of long-term low dose exposure to mixtures of pesticides, food additives and consumer products chemicals on biochemical parameters